The HEL92.1.7 cell line is a human erythroleukemia (HEL) cell line that is widely used in cancer research, particularly in studies related to hematologic malignancies. HEL cells are derived from patients with erythroleukemia, a rare subtype of acute myeloid leukemia (AML) characterized by the abnormal proliferation of immature red blood cell precursors in the bone marrow.
The HEL92.1.7 cell line was established from the HEL cell line and has been extensively characterized for its genetic and molecular features. Researchers use HEL92.1.7 cells as a model system to investigate the pathogenesis of erythroleukemia, including the genetic mutations, chromosomal abnormalities, and signaling pathways that drive the disease.
The HEL92.1.7 cell line serves as a valuable tool for investigating the biology of erythroleukemia and advancing our understanding of this rare form of AML. Its use in research has led to important discoveries in leukemia biology and may lead to the development of novel therapeutic approaches for patients with erythroleukemia in the future.
Organism species: Homo sapiens (Human)
| CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
| Cells | CSI309Hu11 | Human HEL92.1.7 Pure Erythroid Leukemia Cells (HEL92.1.7) | HEL92.1.7 cell line is a valuable tool for researchers studying the pathogenesis of CML, as well as for investigating potential therapeutic strategies for this type of leukemia. |
| Extracts | n/a | Extract of HEL92.1.7 Pure Erythroid Leukemia Cells (HEL92.1.7) | Total Protein/DNA/RNA Extract Customized Service Offer |
| Mediums | MSI309Hu11 | Medium for Human HEL92.1.7 Pure Erythroid Leukemia Cells (HEL92.1.7) | Complete Medium for the culture of HEL92.1.7 cell line |